Paradigm Biopharmaceuticals Limited

ASX:PAR

Paradigm Biopharmaceuticals Limited

ASX:PAR
TradeAdd trade order Follow Unfollow Set Price Alert
$0.360 (+1.4%)
Last close price
#348
Rank
6
Held by
25
Followers
TradeAdd trade order Follow Unfollow Set Price Alert
Reports (5) My Report Forum Investors
Forum Topics PAR PAR Acquisition

Pinned straw:
GazD
Added 5 months ago

Fascinating move by paradigm with the acquisition of a small biotech with the patent rights to a combined COX2 inhibitor - pentosan drug which is given orally.

With The phase 3 trial underway (recruitment started) paradigm are looking to build a platform of OA drugs outside the current options.

the main game remains the phase 3 trial resumes of course

wonkeydonkey
Added 5 months ago

I found this ASX release difficult to digest with the tangent to the therapeutic option for veterinary (horses and dogs) , I think I have reread it several times

13
GazD
Added 5 months ago

Yes @wonkeydonkey I didn’t try to read it with a fine tooth comb but it’s slightly left field. On the upside it is coherent as a strategy to create a suite of products that would treat OA when severe with injections or when more mild with oral pentosan/cox2

9